Catalyst Grant : STBBI Research in Canada: Beyond HIV/AIDS and Hepatitis C

Well-being, Health and Biomedical Discovery


Academic Unit: inquire with unit

Memorial Deadline: Monday 6th, May 2024

External Deadline: Thursday 9th, May 2024


In Canada, sexually transmitted and blood-borne infections (STBBI) disproportionately affect several key populationsi and these disparities reflect the many and often intersecting systemic, biomedical, behavioural and social factors that influence STBBI acquisition, disease progression, access to care, effectiveness of interventions and, ultimately, health outcomes.

Previous targeted investments specific to HIV/AIDS and hepatitis C research have helped develop strong research capacity in these disease-specific areas in Canada; however, there remains a great need to build capacity for research related to other STBBI and invest in research aimed at improving health equity for people living with or at risk of STBBI. This includes research to better understand the determinants of health including the complex interactions and impacts among the many biological, social and structural determinants of health; to develop, test and advance new or improved, culturally-safe and holistic models of care and evidence-based interventions, and to investigate the roles of sex, gender, sexuality and systemic barriers in the experiences, risks and outcomes associated with STBBI. Additionally, discovery research on high burden and emerging STBBI is required to advance next generation interventions that provide better detection, prevention, treatment and care for key populations1.

The overall goal of the Catalyst Grant is to strengthen the current landscape of STBBI research in Canada, and to build capacity and spur innovation in this field, with a specific focus on STBBI of public health relevance beyond the fields of HIV and hepatitis C and in alignment with the CIHR HIV/AIDS and STBBI Strategic Plan 2022-2027.

Research Areas

The CIHR HIV/AIDS and STBBI Research Initiatives defines STBBI as infections that are transmitted primarily through exchange of body fluids during sexual contact and/or through blood. This funding opportunity will support projects across all pillars of research (biomedical research; clinical research; health services research; and social, cultural, environmental, and population health research) with a primary focus on STBBI of public health relevance including, but not limited to:

  • – Chlamydia
  • – Gonorrhea
  • – Syphilis
  • – Hepatitis B
  • – Human papillomavirus (HPV).

Research projects focusing primarily on HIV or hepatitis C will not be eligible for funding. With respect to health conditions common in people living with HIV/AIDS or hepatitis C, the focus of the project must be on at least one of the STBBI listed above or a STBBI of demonstrated public health relevance.

Applications which align with the CIHR HIV/AIDS and STBBI Strategic Plan for 2022-2027 are encouraged, including but not limited to research in the following areas:

  • – Determinants of health
  • – New models of care
  • – Sexual and reproductive health
  • – Innovative technologies for testing and surveillance
  • – Interactions among infections and co-morbidities
  • – Next-generation Interventions

See ResearchNet for more information.

Competition 202405SRC
Application Deadline 2024-05-09

Funding Sources

Canadian Institute of Health Research (CIHR)

This opportunity was posted by: RGCS

Last modified: January 30, 2024